These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 728176)

  • 1. Inhibition of monoamine oxidase by N-phenacyl-cyclopropylamine.
    Fuller RW; Hemrick SK; Mills J
    Biochem Pharmacol; 1978; 27(18):2255-61. PubMed ID: 728176
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective in vivo inhibition of monoamine oxidase in rat tissues by N-[2-(O-chlorophenoxy)-ethyl]-cyclopropylamine.
    Fuller RW; Hemrick SK
    Proc Soc Exp Biol Med; 1978 Jul; 158(3):323-5. PubMed ID: 684000
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective monoamine oxidase inhibitor drugs as aids in evaluating the role of type A and B enzymes.
    Fuentes JA; Neff NH
    Neuropharmacology; 1975 Nov; 14(11):819-25. PubMed ID: 1207877
    [No Abstract]   [Full Text] [Related]  

  • 4. Elevation of epinephrine concentration in rat brain by LY51641, a selective inhibitor of type A monoamine oxidase.
    Fuller RW; Hemrick-Luecke SK
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):207-21. PubMed ID: 7244360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate-selective and tissue-selective inhibition of monoamine oxidase.
    Fuller RW; Roush BW
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):270-6. PubMed ID: 5054735
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced selectivity of pargyline as an inhibitor of type B monoamine oxidase in harmaline-treated rats.
    Fuller RW; Hemrick SK
    Life Sci; 1978 Mar; 22(12):1083-6. PubMed ID: 642716
    [No Abstract]   [Full Text] [Related]  

  • 7. N-[2-(o-iodophenoxy)ethyl]cyclopropylamine hydrochloride (LY121768), a potent and selective irreversible inhibitor of type A monoamine oxidase.
    Fuller RW; Hemrick-Luecke SK; Molloy BB
    Biochem Pharmacol; 1983 Apr; 32(7):1243-9. PubMed ID: 6847714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic studies and effects in vivo of a new monoamine oxidase inhibitor, N-[2-(o-chlorophenoxy)-ethyl]-cyclopropylamine.
    Fuller RW
    Biochem Pharmacol; 1968 Oct; 17(10):2097-106. PubMed ID: 5696879
    [No Abstract]   [Full Text] [Related]  

  • 9. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
    Yang HY; Neff NH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of monoamine oxidation in subfractions of crude mitochondria of rat brain by clorgyline and Lilly 51641.
    Mitra C; Guha SR
    Biochem Pharmacol; 1978; 27(20):2455-7. PubMed ID: 728196
    [No Abstract]   [Full Text] [Related]  

  • 11. The metabolism of indolealkylamines by type A and B monoamine oxidase of brain.
    Neff NH; Yang HY; Goridis C; Bialek D
    Adv Biochem Psychopharmacol; 1974; 11(0):51-8. PubMed ID: 4845688
    [No Abstract]   [Full Text] [Related]  

  • 12. Deprenil: loss of selectivity for inhibition of B-type MAO after repeated treatment.
    Waldmeier PC; Felner AE
    Biochem Pharmacol; 1978 Mar; 27(5):801-2. PubMed ID: 656120
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of the administration of L-5-hydroxytryptophan and a monoamine oxidase inhibitor on glucose metabolism in rat brain.
    Wong KL; Tyce GM
    J Neurochem; 1978 Sep; 31(3):613-20. PubMed ID: 308095
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of N-cyclopropyl-4-chloroamphetamine on brain serotonin metabolism in rats.
    Fuller RW; Molloy BB
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):407-18. PubMed ID: 4750092
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of three monoamine oxidase inhibitors on ethanol preference in mice.
    Sanders B; Collins AC; Petersen DR; Fish BS
    Pharmacol Biochem Behav; 1977 Mar; 6(3):319-24. PubMed ID: 857255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: The use of selective MAO inhibitor drugs to modify amine metabolism in brain.
    Neff NH; Yang HY; Fuentes JA
    Psychopharmacol Bull; 1974 Jul; 10(3):9-10. PubMed ID: 4419491
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective inhibition of monoamine oxidase.
    Fuller RW
    Adv Biochem Psychopharmacol; 1972; 5():339-54. PubMed ID: 4559891
    [No Abstract]   [Full Text] [Related]  

  • 18. Steric influence on inhibition of monoamine oxidase forms by 2,3-dichloro-alpha-methylbenzylamine.
    Fuller RW; Hemrick SK
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):199-202. PubMed ID: 663404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine oxidase inhibition and the induction of ponto-geniculo-occipital wave activity by reserpine in the cat.
    Gershon MD; Brooks DC
    J Pharmacol Exp Ther; 1976 Jun; 197(3):556-66. PubMed ID: 6784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epinephrine accumulation in rat brain after chronic administration of pargyline and LY 51641--comparison with other brain amines.
    Mefford IN; Roth KA; Jurik SM; Collman V; McIntire S; Tolbert L; Barchas JD
    Brain Res; 1985 Jul; 339(2):342-5. PubMed ID: 2411347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.